MiR-210-3p enhances intermittent hypoxia-induced tumor progression via inhibition of E2F3.

Xiao-Bin ZhangYang SongYan-Ting LaiShao-Zhao QiuAn-Ke HuDai-Xi LiNai-Shan ZhengHui-Qing ZengQi-Chang Lin

Published in: Sleep & breathing = Schlaf & Atmung (2023)

IH-induced tumor development is driven through miR-210-3p by E2F3 suppression. MiR-210-3p represents a potential therapeutic target among patients with concomitant cancer and OSA.

Keyphrases

papillary thyroid
high glucose
obstructive sleep apnea
poor prognosis
diabetic rats
squamous cell
high intensity
drug induced
human health
risk assessment
lymph node metastasis
oxidative stress
squamous cell carcinoma
young adults
climate change